Some Experts Defend Niacin For Heart Disease After Failed Study

On Saturday researchers from Oxford University presented data from a 25,673 patient clinical trial funded by Merck that many doctors say should probably end the widespread use of the B vitamin niacin as a heart drug, both because a pill containing extended-release niacin didn't prevent heart attacks and strokes and because it caused increases in diabetes complications, bleeding, and infections.